INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Inogen Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$6.55+0.30 (+4.80%)
Close on Oct 19, 2026
- Market cap
- $177.15M
- P/E (TTM)
- –
- Dividend yield
- –
Inogen Inc revenue by segment
By business segment
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $209.84M | $218.50M | $226.26M | $276.08M | $278.54M | $246.34M | $283.98M | $280.78M | $193.92M | $152.72M | 60.2% | -4.0% |
| Non-U.S. revenue | $138.83M | $117.21M | $89.40M | $101.16M | $79.46M | $62.15M | $77.96M | $77.33M | $55.52M | $50.11M | 39.8% | +18.4% |
From the segment and revenue-disaggregation notes of Inogen's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.